Tarsus Pharmaceuticals, Inc. (TARS)
64.34
-0.45
(-0.69%)
USD |
NASDAQ |
May 21, 10:17
Tarsus Pharmaceuticals Shareholders Equity (Quarterly) : 348.95M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Harrow, Inc. | 28.71M |
| Eton Pharmaceuticals, Inc. | 30.62M |
| ANI Pharmaceuticals, Inc. | 562.30M |
| Corcept Therapeutics, Inc. | 637.99M |
| Assertio Holdings, Inc. | 75.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 581.14M |
| Total Liabilities (Quarterly) | 232.18M |
| Debt to Equity Ratio | 0.2541 |
| Current Ratio | 3.744 |
| Net Debt Paydown Yield | -0.11% |